Drug Safety Communications - FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.

Source

U.S. Food & Drug Administration (FDA)

Link

https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-dental-p…

Year

2017

Format

Web Page

Public domain

Topic

Clinical Guidelines

Adherence, Diversion, & Misuse

Stabilization & Maintenance

Medication Considerations

Patient Engagement

Intake & Induction

Audience

Medical Providers

Behavioral Health Providers

Other Team Members

Patients

Families

Communities

Resource Type

Web Page

Use

Substance Use Disorder Awareness and Education

Special Collection

MAT Tools and Resources